Nephrotic syndrome is a set of signs or symptoms that may point to kidney problems. The kidneys are two-bean shaped organs found in the lower back, each about the size of a fist. They clean the blood by filtering out excess water and salt and waste products from food. Healthy kidneys keep protein in the blood, which helps the blood soak up water from tissues; but kidneys with damaged filters may leak protein into urine. As a result, not enough protein is left in the blood to soak up water. A child with nephrotic syndrome has these signs:
INTRODUCTION
Nephrotic syndrome is a set of signs or symptoms that may point to kidney problems. Both adults and children can have nephrotic syndrome. The causes of and treatments for nephrotic syndrome in children are sometimes different from the causes and treatments in adults. Childhood nephrotic syndrome can occur at any age but is most common between the ages of 1 year 6 months and 5 years. It seems to affect boys more than the girls.
Nephrotic syndrome is an important chronic disease in children, characterized by minimal change disease in the majority. Research on pathogenesis has emphasized the importance of T lymphocyte dysregulation and vascular permeability factors that alters podocyte function and permselectivity. While mutations in genes that encode important podocyte proteins have been identified, a hypothesis unifying available evidence on pathogenesis is yet to be proposed. Patients with nephrotic syndrome are at risk for life-threatening infections and thromboembolic episodes.
The estimated annual incidence of nephrotic syndrome in healthy children is 2 to 7 new cases per 100,000 children younger than 18 years of age, making it a relatively common major disease in pediatrics. Approximately, 50% of affected children are between the ages of 1 year 6 months and 5 years; 75% are younger than 10 years of age. In addition,
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even the most benign form of nephrotic syndrome is, by nature, a recurrent disorder, so each new onset case likely will continue to manifest disease for some time.
Careful examination of the anatomy of a nephron permits characterization of the glomerular basement membrane as the barrier between the circulation and the external environment. Thus, the glomerular membrane, which permits passage in an adult of approximately 180 L/d of fluid, is the final determinant of how much of the solute originally contained in this volume enters the tubular lumen. The normal glomerular membrane is remarkably selective for protein compared with other solutes. Once this selectivity is lost, the ensuing proteinuria defines not only the diagnosis of nephrotic syndrome, but many pathophysiological consequences as well. It is the purpose behind this article to discuss the definition, causes, pathophysiologic consequences, and management of nephrotic syndrome.
DEFINITION
A clinical syndrome characterized by heavy proteinuria, hypoalbuminemia (albumin <25gm/dl), edema and hypercholesterolemia.
Nephrotic syndrome may be primary: • Minimal change nephrotic syndrome disease (MCNS) • Focal segmental glomerulosclerosis (FSGS) or secondary to systemic disease (e.g. lupus). Nephrotic syndrome is a common chronic disorder, characterized by alterations of permselectivity at the glomerular capillary wall, resulting in its inability to restrict the urinary loss of protein. Nephrotic range proteinuria is defined as proteinuria exceeding 1,000 mg/m 2 per day or random urine protein-to-creatinine exceeding 2 mg/mg. The proteinuria in childhood nephrotic syndrome is relatively selective, primarily constituted by albumin. It occurs from 2 to 7 per 100,000 children, and prevalence from 12 to 16 per 100,000. Although the overall incidence of childhood idiopathic nephrotic syndrome has been generally stable over the past 3 decades, 5 the histological pattern is changing. The incidence of FSGS seems to be increasing, in adults and children, even after treatment for changes in renal biopsy Table 2) . Common definitions for defining the course of nephrotic syndrome are listed in Table 3 .
PATHOGENESIS

Primary Glomerular Defect
The glomerular capillary wall consists of three structural elements that constitute the permselectivity barrier: endothelial cells separated by fenestrae, the glomerular basement membrane containing matrix proteins, and podocytes (specialized epithelial cells). Normally, larger proteins (>69 kD) are excluded from filtration; but in nephrotic syndrome, glomeruli appear greatly changed, adjacent podocytes are fused together, assuming a foot-like morphology.
Some observations provide important clues to the primary pathophysiology of idiopathic nephrotic syndrome. Mutations in several podocyte proteins have been identified in families with inherited nephrotic syndrome; a plasma factor may alter glomerular permeability, especially in patients with steroid-resistant nephrotic syndrome and lastly altered T-lymphocyte responses, in that the T-cells could result in the production of a permeability factor that can interfere with the expression, function or both to cause proteinuria.
Nephrin was the first slit-diaphragm protein identified [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] 
Permeability Factor
The role of a systemic circulating factor has been hypothesized in patients with MCNS and FSGS. The clinical response toward immunosuppressive drugs and also lack of inflammatory changes in renal parenchyma suggest an extrarenal factor as causative agent for proteinuria. Various 29 This factor exerts permeability changes in cultured rat glomeruli and is associated with a substantial risk of recurrence of FSGS in a renal allograft.
Immunological Basis
Recent knowledge shows that antigen presentation to T-lymphocytes results in a polarized immune response, which may be type I (dominated by gamma interferons, interleukin-2) or type II (IL-4, IL-10, or IL-13). Type I cytokines predominate in cell-mediated immunity and type II in humoral immunity and are particularly associated with atopy and class switching of B cells for production of IgG4 and IgE. 30 The findings of increased plasma levels of IgE, IgG4 and association with atopy suggest type II cytokine bias in patients with MCNS. Further increased systemic production of representative cytokines, chiefly IL-4 is also reported. 31 In vitro studies suggest that podocytes express receptors for IL-4 and IL-13. 31 Activation of these receptors, by respective cytokines, might disrupt glomerular permeability resulting in proteinuria.
COMPLICATIONS
The chief complications of nephrotic syndrome is infection, followed by thromboembolic events. Hypertension, hyperlipidemia, features of corticosteroid toxicity and behavioral disorders are less frequent.
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Infections: Increased predisposition to infections occur due to loss of immunoglobulins, complement and prosperdin, altered T-cell functions, immunosuppressive therapy and presence of edema. Peritonitis, has an incidence of 2 to 6%, 1 other common infections include cellulitis, pneumonias and upper respiratory viral infections. 33 Varicella and pneumococcal vaccination is recommended for all children with nephrotic syndrome once they are in remission and off steroid therapy.
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Embolism: Patients with nephrotic syndrome are at an increased risk for arterial and venous thrombosis, 35 additional predisposing factors include volume depletion, infections, diuretic use, venepuncture and immobilization. 35 Patients with clinical and radiological evidence of thrombosis are initially treated with heparin or low molecular weight heparin; the latter is preferred because it is more effective and also convenient to administer. Presently, they are no longer in use.
Hyperlipidemia: In most patients is transient and does not have long-term implications. 3 However, raised blood levels of lipids may persist in patients with steroid resistant nephrotic syndrome and potentially contribute to cardiovascular morbidity and glomerulosclerosis. 36 Patients are advised to achieve a normal weight to height ratio, and diet should be restricted in saturated fats.
Osteoporosis:
The risk of steroid-induced osteoporosis has significant long-term implications. A prospective study from India 37 showed that 22 of 100 patients with nephrotic syndrome had features suggestive of low bone mass. Factors predictive of low bone mass were older age at onset, low calcium intake and cumulative steroid dosage. 37 Leonard et al 38 examined the bone mineral content in 60 children with nephrotic syndrome and 195 controls, and showed that while the bone mineral content of the spine was lower in patients, the whole body mineral content was higher than controls.
DIAGNOSIS
Once diagnosed, a series of questions should be asked to establish a cause for the nephrotic syndrome (Table 2 ). Since MCNS is by far the most common cause of nephrotic syndromes in childhood, initial efforts are devoted to the detection of features that are similar to MCNS. A course of corticosteroid treatment without a renal biopsy is indicated for children without atypical features, since responsiveness to steroids is a better indicator than kidney histology of longterm prognosis for renal function. Renal biopsy is done when there is poor or no response of the initial episode after 4 to 6 weeks of standard treatment 
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(defined as steroid-resistant disease), and the child should be medically stable. The biopsy is essential to distinguish the nature and severity of the glomerular process, which may be primary or secondary. Because proteinuria and microscopic hematuria are injury responses of the glomerulus, the need for clarification through renal biopsy is plain. The indications for initial renal biopsy in the nephrotic syndrome are summarized in Table 4 . Technological developments in ultrasonography have reduced significantly the risk associated with percutaneous renal biopsy in children. Moreover, the improvements in electron microscopy equipment and technique, have enhanced the ability of the histopathologist to interpret the specimen accurately. Nonetheless, a renal biopsy is not always essential to good medical care, and its use should be viewed judiciously in all patients.
TREATMENT
Treatment of Initial Presentation of Nephrotic Syndrome
Prednisolone: When the diagnosis of nephrotic syndrome has been made, prednisolone can be started in children with typical features; for children with atypical features, they should be referred to pediatric nephrology for consideration of renal biopsy. 39 There is increasing evidence that longer initial course of prednisolone are associated with a lower incidence of relapse, and therefore a 12 weeks initial course is recommended. The dosage of prednisolone is based on the surface area.
• 60 mg/m Prednisolone can be given as a single dose in the morning with food, or as divided doses during the day, and patients have to be issued a steroid warning.
Albumin: Is indicated in clinical hypovolemia and symptomatic edema. A low serum albumin is not an indication for intravenous albumin. If there is evidence of hypovolemia, give 1 gm/kg 20% albumin (5 ml/kg) over 4 to 6 hours. Give 2 mg/kg of IV furosemide midinfusion. If clinically shocked, give 10 ml/kg 4.5% albumin. Children should be closely monitored during albumin infusions, and where possible should be administered during working hours.
Penicillin prophylaxis: Penicillin V can be given during proteinuria and discontinued when the child goes into remission. Grossly edematous children are at risk of cellulitis and may benefit from antibiotic prophylaxis.
Dose: Under 5 years-125 mg bid and for above 5 years 250 mg bid.
Salt/Fluid restriction:
A low salt diet is used to prevent further fluid retention and also edema. Fluid restriction may also be helpful.
Vaccination: Pneumococcal vaccination is recommended for children with nephrotic syndrome. Varicella vaccination is only available on a named patient basis.
Treatment of Relapse Nephrotic Syndrome
Upto 60 to 70% of children with nephrotic syndrome may have one or more relapse. These are diagnosed if there is +++ or ++++ proteinuria for 3 or more days. Urine should be checked initially twice weekly, then weekly after the first episode, and the families should be instructed to get in contact in case a relapse of proteinuria occur, or if there is ++ for more than 1 week.
Prednisolone: Should be restarted once a relapse has been diagnosed: • 2 mg/kg daily (maximum 80 mg) until the urine is negative or trace for 3 days.
• 40 mg/m 2 /on alternate days for 4 weeks (maximum 60 mg) then stop or taper the dose over 4 to 8 weeks.
Albumin:
The indications are similar as for initial presentation.
Salt/Fluid restriction: During proteinuria, no salt diet is advised. Table 4 : Indications for initial renal biopsies in nephrotic syndrome
1. Patients having steroid-resistant nephrotic syndrome and continue to have proteinuria despite a full course of prednisolone 2. Patients having steroid-responsive nephrotic syndrome and have more than two relapses in a 6-month period (also called 'frequent relapsers') 3. Patients who have a low serum complement at the time of initial presentation of nephrotic syndrome. Biopsy is indicated to rule out hypocomplementemic membranoproliferative glomerulonephropathies 4. Nephrotic syndrome with hypertension at presentation; the risk of FSGS is higher 5. Patients younger than 1 year of age at presentation. Biopsy is indicated because of a high likelihood of congenital nephrotic syndrome 6. Patients older than 10 years of age at presentation. Biopsy is indicated to rule out more serious pathology than minimal-change disease 7. Systemic lupus erythematosus with proteinuria or nephrotic syndrome 8. Evidence of chronic renal insufficiency with persistent elevation of serum urea nitrogen and creatinine Penicillin prophylaxis: During proteinuria, penicillin can be given.
Vaccination: Consider giving varicella vaccine between relapses in children who are varicella seronegative.
Referral to pediatric nephrology in cases of: • Frequent relapsers • Steroid dependency • Steroid toxicity.
Diagnosis and Treatment of Frequent Relapses
Frequent relapsers are diagnosed if there is: • 2 or more relapses within the first 6 months of presentation • 4 or more relapses within any 12-month period.
This becomes steroid dependency. If the relapses are occurring during steroid tapering, varicella status should be repeated 6 monthly in those who are nonimmune.
Low dose alternate day prednisolone:
In the dose of 10 to 15 mg/alternate days may prevent relapses.
Levamisole: Levamisole may be beneficial for children who have occasional relapses. It is less useful for children who are steroid dependent. The dose is 2.5 mg/kg on alternate days for 6 months to a year. Reversible neutropenia is rare but occurs sometimes, and a FBC should be checked monthly for the first 3 months.
Cyclophosphamide: Can be given in the dose of 3 mg/kg/ day for 8 weeks.
Cyclosporin: At a dose of 2.5 mg/kg bid usually for 1 year may be useful as a steroid sparing agent. Levels should be checked after 1 to 2 weeks. For children under 5 years, tid dosing may be necessary. Monitor BP and renal function.
Mycophenolate mofetil (MMF):
Can be given to children showing signs of cyclosporin toxicity. Doses of 600/m
